CN115804805B - Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag - Google Patents
Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag Download PDFInfo
- Publication number
- CN115804805B CN115804805B CN202211702614.5A CN202211702614A CN115804805B CN 115804805 B CN115804805 B CN 115804805B CN 202211702614 A CN202211702614 A CN 202211702614A CN 115804805 B CN115804805 B CN 115804805B
- Authority
- CN
- China
- Prior art keywords
- ankylosing spondylitis
- traditional chinese
- bag
- chinese medicine
- external
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 206010002556 Ankylosing Spondylitis Diseases 0.000 title claims abstract description 23
- 239000000203 mixture Substances 0.000 title abstract description 16
- 150000001875 compounds Chemical class 0.000 title abstract description 15
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 7
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000173529 Aconitum napellus Species 0.000 claims abstract description 6
- 229910052891 actinolite Inorganic materials 0.000 claims abstract description 6
- 229940116229 borneol Drugs 0.000 claims abstract description 6
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 6
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 5
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 5
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 5
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 5
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 5
- 241000195954 Lycopodium clavatum Species 0.000 claims abstract description 5
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims abstract description 5
- 241000758794 Asarum Species 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 7
- 241000427159 Achyranthes Species 0.000 claims description 5
- 241000208682 Liquidambar Species 0.000 claims description 4
- 235000006552 Liquidambar styraciflua Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims description 4
- 235000014066 European mistletoe Nutrition 0.000 claims description 3
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 244000152640 Rhipsalis cassutha Species 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 14
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 229940023019 aconite Drugs 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 241000316342 Taxillus Species 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 238000010792 warming Methods 0.000 abstract description 2
- 208000008035 Back Pain Diseases 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 6
- 208000008930 Low Back Pain Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000017965 Asarum canadense Nutrition 0.000 description 3
- 235000000385 Costus speciosus Nutrition 0.000 description 3
- 241000606265 Valeriana jatamansi Species 0.000 description 3
- 235000014687 Zingiber zerumbet Nutrition 0.000 description 3
- 208000019804 backache Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000717739 Boswellia sacra Species 0.000 description 2
- 241000903946 Clematidis Species 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- 241001057584 Myrrha Species 0.000 description 2
- 241000221012 Viscum Species 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241001550206 Colla Species 0.000 description 1
- 241000209020 Cornus Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000009266 disease activity Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000009760 functional impairment Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
A Chinese medicinal compound composition for treating ankylosing spondylitis and an external medicinal bag belong to the technical field of Chinese medicinal compounds for treating ankylosing spondylitis, and consist of 15-25g of Chinese taxillus twig, 15-25g of radix achyranthis bidentatae, 5-15g of cassia twig, 5-20g of lycopodium clavatum, 5-15g of safflower, 5-15g of mugwort leaf, 5-20g of garden balsam stem, 10-15g of aconite, 5-15g of radix aconiti, 10g of asarum, 5-15g of fructus liquidambaris, 5-15g of borneol, 10-15g of cortex acanthopanacis, 10-15g of herba aristolochiae, 5-10g of fructus polygoni orientalis and 25-35g of actinolite. The invention is prepared according to the principle of monarch, minister, assistant and guide, and has the effects of tonifying kidney, strengthening governor meridian, warming channel, dredging collaterals, activating blood and relieving pain. Meanwhile, the external medicine bag can penetrate into the human body through the channels and collaterals on the surface of the human body, so that better treatment effect is exerted.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicine compounds for treating ankylosing spondylitis, and particularly relates to a traditional Chinese medicine compound composition for treating ankylosing spondylitis and an external medicine bag.
Background
Ankylosing spondylitis (ankylosing spondylitis, AS) is a common inflammatory rheumatic disease affecting the central axis bone, causing characteristic inflammatory back pain, which can lead to structural and functional impairment and reduced quality of life. The incidence of AS in chinese population is similar to that of european population, about 0.24%. About 4% of patients lost some of their labor after 5 years of onset of AS, and about 50% of patients lost some of their labor after 45 years of onset. The pathogenesis of AS is not well known and may be related to genetics, infections, environment, immunity, etc. The key to treatment is to relieve the inflammatory symptoms of AS patients AS soon AS possible, relieve pain, control the disease activity, delay the progression of the disease, and reduce the teratogenic and disabling injuries of the patients caused by the disease. However, the existing AS therapeutic drugs include nonsteroidal anti-inflammatory drugs, immunosuppressants, antirheumatic drugs, glucocorticoids and the like for improving the illness state, have large side effects after long-term administration, have intolerance, have adverse reactions such AS affected gastrointestinal liver and kidney functions and the like, and cause heavy physical and psychological burden for patients.
The traditional Chinese medicine can effectively improve clinical symptoms of AS patients and reduce toxic and side effects, thereby further improving the life quality of patients. Chinese patent application CN103893427A discloses a traditional Chinese medicine composition for treating ankylosing spondylitis and a preparation method thereof, and the traditional Chinese medicine composition is prepared from the following raw materials: radix Puerariae, radix Angelicae sinensis, radix Paeoniae alba, radix rehmanniae Preparata, herba Epimedii, colla Cornus Cervi, fructus Lycii, radix Pseudostellariae, notopterygii rhizoma, radix Angelicae Pubescentis, radix Paeoniae Rubra, corni fructus, herba Taxilli, radix Dipsaci, ramulus Cinnamomi, saviae Miltiorrhizae radix, caulis Spatholobi, fructus Lycii, fructus Ligustri Lucidi, cistanchis herba, achyranthis radix, rhizoma Drynariae, rhizoma Cibotii, eucommiae cortex, rhizoma Curculiginis, polygoni Multiflori radix, radix Morindae officinalis, fructus Ligustri Lucidi, radix scrophulariae, radix aucklandiae, rhizoma Ligustici Chuanxiong, poria, radix Gentianae Marcrophyllae, radix Saposhnikoviae, radix Cyathulae, herba asari, ramulus Cinnamomi, radix Clematidis, radix Aconiti Preparata, myrrha, olibanum Preparata, glycyrrhrizae radix and squama Manis. The traditional Chinese medicine composition has the advantages of safe propaganda and clinical application, no irritation to viscera after oral administration, convenience for taking the preparation, guarantee of the purity of the medicine, convenience for storage, remarkable curative effect, multiple absorption of active ingredients, good performance of medicine property, treatment of both principal and secondary aspect of disease, and total effective rate up to 97%.
Chinese patent application CN106619988A discloses a traditional Chinese medicine foot bath powder for treating lumbago and skelalgia and a preparation method thereof, wherein the formula comprises the following components: ramulus Cinnamomi, radix Saposhnikoviae, folium Artemisiae Argyi, herba Schizonepetae, notopterygii rhizoma, radix Angelicae Pubescentis, herba Taxilli, cortex Acanthopancis, carthami flos each 20g, eucommiae cortex, radix Angelicae sinensis, cortex Cinnamomi, radix rehmanniae Preparata, radix Dipsaci, herba Lycopodii, herba Speranskiae Tuberculatae, radix Angelicae Dahuricae, ramulus Mori, lignum sappan, radix Clematidis each 30g, and radix Olibanum, myrrha, radix Cyathulae, and Achyranthis radix each 16g. The preparation is foot bath powder, and has good therapeutic effect on lumbago and skelalgia.
Disclosure of Invention
The invention aims to solve the technical problem of providing a traditional Chinese medicine compound composition and an external medicine bag for treating ankylosing spondylitis, which are prepared according to the principle of monarch, minister, assistant and guide prescription, and are used for tonifying kidney, strengthening governor meridian, warming channel, dredging collaterals, activating blood and relieving pain. Meanwhile, the external medicine bag can penetrate into the human body through the channels and collaterals on the surface of the human body, so that better treatment effect is exerted.
In order to achieve the above purpose, the technical scheme adopted by the invention is as follows:
a Chinese medicinal compound composition for treating ankylosing spondylitis is prepared from the following Chinese medicinal raw materials in part by weight:
15-25g of Chinese taxillus twig, 15-25g of achyranthes root, 5-15g of cassia twig, 5-20g of lycopodium clavatum, 5-15g of safflower, 5-15g of mugwort leaf, 5-20g of garden balsam stem, 10-15g of aconite, 5-15g of common monkshood mother root, 10g of manchurian wildginger, 5-15g of beautiful sweetgum fruit, 5-15g of borneol, 10-15g of cortex acanthopanacis, 10-15g of herba aristolochiae, 5-10g of water safflower seed and 25-35g of actinolite.
The Chinese herbal compound composition of the invention has the following treatment rules: tonify kidney, strengthen governor meridian, warm meridians, activate blood and relieve pain. Because ankylosing spondylitis patients take lumbago and backache as main symptoms, the ankylosing spondylitis patients belong to the category of arthralgia syndrome in traditional Chinese medicine, and are mainly caused by pain caused by obstruction, and the patients have deficiency of spleen and kidney, deficiency of vital qi, easy invasion of exogenous evil, and obstruction of qi and blood circulation, and are caused by stasis, and pain caused by obstruction. Therefore, in the compound composition, the Chinese taxillus herb and the achyranthes root are monarch drugs, and can tonify liver and kidney and dispel wind-damp. Ramulus Cinnamomi, radix Aconiti lateralis Preparata, herba asari, folium Artemisiae Argyi, and radix et rhizoma Rhei Wu Wenjing for dredging collaterals, cortex Acanthopanacis, fructus Lipuidambaris, herba Aristolochiae Mollissimae, herba Speranskiae Tuberculatae, and herba Lycopodii for dispelling pathogenic wind, removing dampness, and relieving arthralgia, and can be used as ministerial drugs. Safflower and fructus polygoni orientalis have the effects of promoting blood circulation, removing blood stasis and relieving pain, actinolite tonifies kidney and dispels cold, and are taken as adjuvant drugs together, borneol Xin Tou has the effects of inducing resuscitation, relieving pain, and white spirit has the effects of promoting blood circulation and dredging channels as guide, and all drugs are led to directly reach the disease site. The external therapeutic principle can be used for curing ankylosing spondylitis by penetrating the channels and collaterals of the body surface of the human body.
As a preferable technical scheme of the traditional Chinese medicine compound composition for treating ankylosing spondylitis, the traditional Chinese medicine compound composition is prepared from the following traditional Chinese medicine raw materials in parts by weight:
20g of mistletoe, 20g of achyranthes root, 10g of cassia twig, 10g of lycopodium clavatum, 10g of safflower, 10g of mugwort leaf, 10g of garden balsam stem, 10g of aconite, 10g of manchurian wildginger, 10g of beautiful sweetgum fruit, 10g of borneol, 10g of cortex acanthopanacis, 10g of herba aristolochiae, 10g of fructus polygoni orientalis and 30g of actinolite.
The invention also provides an external medicine bag prepared by using the Chinese herbal medicine compound composition, which is prepared by crushing the Chinese herbal medicines, sprinkling a proper amount of white spirit into the medicinal powder, uniformly mixing the medicinal powder, and placing the medicinal powder into a cloth bag.
The traditional Chinese medicine compound composition can be used for treating ankylosing spondylitis and has a good treatment effect. The external medicine bag can be made into the medicine bag which can penetrate into human body through the channels and collaterals of the surface of the human body, thereby playing a better therapeutic role.
Detailed Description
The present invention is described in further detail below with reference to examples.
Example 1
An external medicine bag for treating ankylosing spondylitis:
the compound composition comprises the following components: 20g of mistletoe, 20g of achyranthes root, 10g of cassia twig, 10g of lycopodium clavatum, 10g of safflower, 10g of mugwort leaf, 10g of garden balsam stem, 10g of aconite, 10g of manchurian wildginger, 10g of beautiful sweetgum fruit, 10g of borneol, 10g of cortex acanthopanacis, 10g of herba aristolochiae, 10g of fructus polygoni orientalis and 30g of actinolite.
The preparation method comprises the following steps: pulverizing the above materials, sprinkling 200g of Chinese liquor into the powder, mixing the powder, and placing into cloth bag to obtain topical medicated bag.
Before use, the powder is put into a microwave oven for heating for 3 minutes, and then is put into the waist and back of a patient suffering from ankylosing spondylitis for hot compress.
Example 2
Efficacy statistics
60 cases of ankylosing spondylitis patients (patients in the first affiliated hospital clinic of Anhui university of traditional Chinese medicine) were given the external medicine package treatment prepared according to the method of example 1; of these, 56 men and 4 women, aged 20-28 years, with an average age of 24 years. The course of the disease is 0.5-5 years. Clinical manifestations are efficacy assessment criteria of pain in the waist and back, stiffness, limited activity, etc.:
(1) And (3) curing: after 2 courses of treatment with the topical medicated bag, pain symptoms of patients disappear, and joints can move normally;
(2) And (3) the following steps: after 2 treatment courses of the external medicine bag treatment, the pain symptoms of the patient basically disappear, and the joint mobility is improved;
(3) Invalidation: pain and joint limitation did not improve or even aggravate after 2 courses of topical drug treatment.
Efficacy assessment results:
after 60 patients with ankylosing spondylitis are treated by using the external medicine bag for 2 treatment courses, 4 patients are cured, and the patients are effectively treated by 52 patients and are not treated by 4 patients. The total effective rate is very obvious.
Example 3
Typical cases
Case 1
Duan Mou A, 26 years old, pain in the waist and back is 2 years old, pain in the waist and back is not caused by clear causes before 2 years, pain in the night is obvious, soreness of the waist and knees is accompanied, the weather changes and aggravation after tiredness are carried out, fatigue and debilitation are obvious, ankylosing spondylitis is diagnosed after perfecting the relevant examination, and after 2 treatment courses, the external medicine bag is used for treating, the pain in the waist and back is not obvious, the night is sleep and the symptom is not repeated.
Case 2
Feng Mou it is used for men, 25 years old, and has the effects of relieving pain in waist and back, pain at night, stiffness in morning, and pain after activity. After 2 treatment courses, the symptoms of the lumbago and backache gradually disappear and do not recur.
Case 3
Liu Mou female, 28 years old, had back pain for 3 years, and had back pain and night pain evident. Various medicines are taken once, various treatment modes (acupuncture, massage and the like) are tried, the treatment effect is not obvious, and after 2 treatment courses of treatment by using the external medicine bag, the symptoms of the lumbago and backache gradually disappear and do not relapse.
The foregoing is merely illustrative and explanatory of the principles of the invention, as various modifications and additions may be made to the specific embodiments described, or similar thereto, by those skilled in the art, without departing from the principles of the invention or beyond the scope of the appended claims.
Claims (2)
1. A traditional Chinese medicine external medicine bag for treating ankylosing spondylitis is characterized by being prepared from the following traditional Chinese medicine raw materials in parts by weight: 20g of mistletoe, 20g of achyranthes root, 10g of cassia twig, 10g of lycopodium clavatum, 10g of safflower, 10g of mugwort leaf, 10g of garden balsam stem, 10g of accessory piece, 10g of common monkshood mother root, 10g of asarum herb, 10g of beautiful sweetgum fruit, 10g of borneol, 10g of cortex acanthopanacis, 10g of herba aristolochiae, 10g of fructus polygoni orientalis and 30g of actinolite;
the preparation method of the traditional Chinese medicine external-use medicine bag comprises the following steps: pulverizing the above materials, sprinkling appropriate amount of Chinese liquor into the medicinal powder, mixing the medicinal powder, and placing into cloth bag to obtain topical medicinal bag.
2. The use of the external pack according to claim 1 for the preparation of a medicament for the treatment of ankylosing spondylitis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211702614.5A CN115804805B (en) | 2022-12-29 | 2022-12-29 | Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211702614.5A CN115804805B (en) | 2022-12-29 | 2022-12-29 | Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115804805A CN115804805A (en) | 2023-03-17 |
| CN115804805B true CN115804805B (en) | 2023-10-27 |
Family
ID=85487080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211702614.5A Active CN115804805B (en) | 2022-12-29 | 2022-12-29 | Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115804805B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202008002953U1 (en) * | 2008-03-01 | 2008-07-03 | Reither, Robert, Dr. | Chinese herbal recipes for the treatment of musculoskeletal disorders in humans and animals |
| CN104096022A (en) * | 2014-07-29 | 2014-10-15 | 张宗云 | External use compound Chinese herbal preparation for treating ankylosing spondylitis and preparation method thereof |
| CN106389720A (en) * | 2016-10-25 | 2017-02-15 | 李本虎 | Medicine for treating ankylosing spondylitis and preparation method thereof |
-
2022
- 2022-12-29 CN CN202211702614.5A patent/CN115804805B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202008002953U1 (en) * | 2008-03-01 | 2008-07-03 | Reither, Robert, Dr. | Chinese herbal recipes for the treatment of musculoskeletal disorders in humans and animals |
| CN104096022A (en) * | 2014-07-29 | 2014-10-15 | 张宗云 | External use compound Chinese herbal preparation for treating ankylosing spondylitis and preparation method thereof |
| CN106389720A (en) * | 2016-10-25 | 2017-02-15 | 李本虎 | Medicine for treating ankylosing spondylitis and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 中药熏蒸治疗强直性脊柱炎临床观察;庞立波, 王素美, 丁立钧, 金新美;山东中医杂志;22(04);第208页左栏第1段，右栏第3段以及第209页 讨论部分 * |
| 止痹方蒸气浴治疗强直性脊柱炎43例;李晓妮;杨淑彬;;陕西中医;34(07);第847页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115804805A (en) | 2023-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101559204B (en) | Traditional Chinese medicine compound treating irregular menstruation and dysmenorrheal and application thereof in preparing hygienic products of women | |
| CN102973862B (en) | Chinese medicine preparation for treating skin itch | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN100584354C (en) | A medicine for treating zoster sequela neuralgia | |
| CN1317021C (en) | Chinese medicinal formulation for stopping pain for removing Bi | |
| CN103251766A (en) | Chinese medicine composition, and clinical preparation and preparation method thereof | |
| CN102698220A (en) | Traditional Chinese medicine formula for treating scapulohumeral periarthritis | |
| CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
| CN115804805B (en) | Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag | |
| CN1115165C (en) | Externally applied medicated wine for treating traumatic injury and rheumatism | |
| CN101342245A (en) | Traditional Chinese medicine for treating rheumatism | |
| CN103830672A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN102670919A (en) | Chinese medicament for treating chronic pyelonephritis | |
| CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
| CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN104383064A (en) | Formula of Chinese herbal medicine for treating cervicitis | |
| CN1060073C (en) | Externally used medicine bag for curing chronic pelvic infection, endometriosis, chronic cervicitis and menalgia and its making process | |
| CN103877191A (en) | Medicament for treating bone and joint diseases | |
| CN102861197A (en) | Traditional Chinese medicine composition for treating injuries from falls, fractures, contusions and strains | |
| CN102068647A (en) | Chinese medicinal composition for treating lumbocrural pains by ironing and warming | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN106309576A (en) | Drug for treating haemorrhoids and preparation method thereof | |
| CN105770626A (en) | Traditional Chinese medicine composition for treating epifolliculitis | |
| CN115089653A (en) | Traditional Chinese medicine composition for treating rheumatism and cervical and lumbar diseases and application thereof | |
| CN104623333A (en) | Drug for treating facial paralysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |